Conversations That Matter No deviation’s Takeaways from 2025 ISPE France Conference – Validation of AI in the pharmaceutical industry. Presentation of a validation strategy for
With No deviation now established in China, we’re taking a closer look at China’s regulatory landscape and its global connections. Understanding how the NMPA (National
Conversations That Matter No deviation’s Takeaways from 2025 ISPE Conference in Singapore Speaker: Dave O’Connor, C&Q Digital Transformation Manager at No deviation, One of the
A leading pharmaceutical client, using Kneat since 2019, partnered with No deviation for a critical upgrade from version 8.8 to 9.3. Their goal: improve system
Digital Validation Takes Center Stage April 2025 marks a major milestone in the pharmaceutical and life sciences industries: the publication of ISPE’s Good Practice Guide:
The pharmaceutical industry is under constant pressure to deliver safe, compliant products while accelerating time-to-market. Traditional paper-based validation processes are time-consuming, error-prone, and difficult to
438A Alexandra Rd, #01-07/08 Alexandra Technopark,
Singapore 119967